Agency Forms Undergoing Paperwork Reduction Act Review, 32124-32126 [2018-14796]
Download as PDF
32124
Federal Register / Vol. 83, No. 133 / Wednesday, July 11, 2018 / Notices
category for purposes of applying the
disclosure thresholds.
OGE is also proposing to update the
Privacy Act Statement in accordance
with changes to the applicable system of
records, update the examples provided
on the last page of the form, and make
other minor technical changes.
Request for Comments: OGE is
publishing this first round notice of its
intent to request paperwork clearance
for a proposed modified OGE Form 450.
Public comment is invited specifically
on the need for and practical utility of
this information collection, the accuracy
of OGE’s burden estimate, the
enhancement of quality, utility and
clarity of the information collected, and
the minimization of burden (including
the use of information technology).
Comments received in response to this
notice will be summarized for, and may
be included with, the OGE request for
extension of OMB paperwork approval.
The comments will also become a
matter of public record.
Approved: July 3, 2018.
David Apol,
Acting Director and General Counsel, Office
of Government Ethics.
[FR Doc. 2018–14841 Filed 7–10–18; 8:45 am]
BILLING CODE 6345–03–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis Meeting (ACET)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Advisory Council for the
Elimination of Tuberculosis Meeting
(ACET). This meeting is open to the
public, limited only by 60 room seating
and 100 ports for audio phone lines.
Time will be available for public
comment. The public is welcome to
submit written comments in advance of
the meeting. Comments should be
submitted in writing by email to the
contact person listed below. The
deadline for receipt is Monday, August
13, 2018. Persons who desire to make an
oral statement, may request it at the
time of the public comment period on
August 21, 2018 at 3:20 p.m., EDT.
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:26 Jul 10, 2018
Jkt 244001
The meeting will be held on
August 21, 2018, 10:00 a.m. to 3:30
p.m., EDT.
DATES:
8 Corporate Blvd., Building
8, Conference Rooms 1A and 1B,
Atlanta, Georgia 30329 and Web
conference: 1–877–927–1433 and
participant passcode: 12016435 and
https://adobeconnect.cdc.gov/
r5p8l2tytpq/.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Margie Scott-Cseh, Committee
Management Specialist, CDC, 1600
Clifton Road NE, Mailstop: E–07,
Atlanta, Georgia 30329–4018, telephone
(404) 639–8317; zkr7@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: This Council advises and
makes recommendations to the
Secretary of Health and Human
Services, the Assistant Secretary for
Health, and the Director, CDC, regarding
the elimination of tuberculosis.
Specifically, the Council makes
recommendations regarding policies,
strategies, objectives, and priorities;
addresses the development and
application of new technologies; and
reviews the extent to which progress has
been made toward eliminating
tuberculosis.
Matters To Be Considered: The agenda
will include discussions on (1)
Isoniazid-Rifapentine TB Prevention in
HIV-infected Persons Study; (2) Division
of HIV/AIDS Prevention’s Strategy of
Adopting HIV Treatment as Prevention;
(3) Update on Division of Tuberculosis
Elimination’s Concept of Operations for
Latent Tuberculosis Infection
Surveillance; and (4) Update from ACET
workgroups. Agenda items are subject to
change as priorities dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–14755 Filed 7–10–18; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Breast Cancer
in Young Women, Centers for Disease
Control and Prevention; Notice of
Charter Renewal
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of charter renewal.
AGENCY:
This gives notice under the
Federal Advisory Committee Act of
October 6, 1972, that the Advisory
Committee on Breast Cancer in Young
Women (ACBCYW), Centers for Disease
Control and Prevention, Department of
Health and Human Services, has been
renewed for a 2-year period through
June 17, 2020.
FOR FURTHER INFORMATION CONTACT:
Temeika L. Fairley, Ph.D., Designated
Federal Officer, National Center for
Chronic Disease Prevention and Health
Promotion, CDC, 5770 Buford Highway
NE, Mailstop K52, Atlanta, Georgia
30341, Telephone (770) 488–4518, Fax
(770) 488–4760. Email: acbcyw@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
SUMMARY:
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–14756 Filed 7–10–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–18–0572]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Health Message
Testing System (HMTS) to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
E:\FR\FM\11JYN1.SGM
11JYN1
Federal Register / Vol. 83, No. 133 / Wednesday, July 11, 2018 / Notices
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on May 10,
2018 to obtain comments from the
public and affected agencies. CDC
received one non-substantive comment.
This notice serves to allow an additional
30 days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
daltland on DSKBBV9HB2PROD with NOTICES
Proposed Project
Health Message Testing System
(HMTS) 0920–0572, Reinstatement
without change, Office of the Associate
Director for Communication (OADC),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Before CDC disseminates a health
message to the public, the message
always undergoes scientific review.
However, even though the message is
based on sound scientific content, there
is no guarantee that the public will
understand a health message or that the
VerDate Sep<11>2014
16:26 Jul 10, 2018
Jkt 244001
message will move people to take
recommended action. Communication
theorists and researchers agree that for
health messages to be as clear and
influential as possible, target audience
members or representatives must be
involved in developing the messages
and provisional versions of the
messages must be tested with members
of the target audience.
However, increasingly there are
circumstances when CDC must move
swiftly to protect life, prevent disease,
or calm public anxiety. Health message
testing is even more important in these
instances, because of the critical nature
of the information need.
In the interest of timely health
message dissemination, many programs
forgo the important step of testing
messages on dimensions such as clarity,
salience, appeal, and persuasiveness
(i.e., the ability to influence behavioral
intention). Skipping this step avoids the
delay involved in the standard OMB
review process, but at a high potential
cost. Untested messages can waste
communication resources and
opportunities because the messages can
be perceived as unclear or irrelevant.
Untested messages can also have
unintended consequences, such as
jeopardizing the credibility of Federal
health officials.
The Health Message Testing System
(HMTS), a generic information
collection, enables programs across CDC
to collect the information they require
in a timely manner to:
• Ensure quality and prevent waste in
the dissemination of health information
by CDC to the public.
• Refine message concepts and to test
draft materials for clarity, salience,
appeal, and persuasiveness to target
audiences.
• Guide the action of health
communication officials who are
responding to health emergencies,
Congressionally-mandated campaigns
with short timeframes, media-generated
public concern, time-limited
communication opportunities, trends,
and the need to refresh materials or
dissemination strategies in an ongoing
campaign.
Each testing instrument will be based
on specific health issues or topics.
Although it is not possible to develop
one instrument for use in all instances,
the same kinds of questions are asked in
most message testing. This package
includes generic questions and formats
that can used to develop health message
testing data collection instruments.
These include a list of screening
questions, comprised of demographic
and introductory questions, along with
other questions that can be used to
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
32125
create a mix of relevant questions for
each proposed message testing data
collection method. However, programs
may request to use additional questions
if needed.
Message testing questions will focus
on issues such as comprehension,
impressions, personal relevance,
content and wording, efficacy of
response, channels, and spokesperson/
sponsor. Such information will enable
message developers to enhance the
effectiveness of messages for intended
audiences.
Data collection methods proposed for
HMTS include intercept interviews,
telephone interviews, focus groups,
online surveys, and cognitive
interviews. In almost all instances, data
will be collected by outside
organizations under contract with CDC.
For many years CDC programs have
used HMTS to test and refine message
concepts and test draft materials for
clarity, salience, appeal, and
persuasiveness to target audiences.
Having this generic clearance available
has enabled them to test their
information and get critical health
information out to the public quickly.
Over the last three years, more than 30
messages have been tested using this
clearance. For example: Domestic
Readiness Initiative on Zika Virus
Disease-Year 2 Core Campaign
Materials. As part of the mission of
CDC’s Domestic Readiness Initiative on
the Zika Virus Disease, CDC collected
information to inform an outcome
evaluation to determine the extent to
which the campaign affected awareness,
attitudes, and intention to follow
recommended behaviors at different
points during the campaign. The goal of
the evaluation was to better understand
awareness of campaign activities, how
people perceive Zika as a health risk,
and assess their uptake of recommended
health behaviors, such as applying
insect repellent, using condoms, and
wearing long-sleeved clothing.
The Division of Unintentional Injury
Prevention obtained OMB approval
through HMTS for Assessing Perception
and Use of CDC Guideline for
Prescribing Opioids for Chronic Pain.
The purpose of this collection is to
assess primary care physician’s
perceptions and use of communication
materials and products associated with
the CDC Guideline for Prescribing
Opioids for Chronic Pain. Information
collected can assist in the most effective
use of CDC communication resources
and opportunities by assessing clarity,
salience, appeal, persuasiveness and
effectiveness of materials promoting the
dissemination and implementation of
the Guideline. Specifically, CDC seeks
E:\FR\FM\11JYN1.SGM
11JYN1
32126
Federal Register / Vol. 83, No. 133 / Wednesday, July 11, 2018 / Notices
to understand how primary care
physicians perceive, need, and
implement the Guideline to make
prescribing decisions; how they need,
obtain, and use supplementary and
promotional Guideline materials
developed by CDC for professional
development or patient education; and
critical to programs in disseminating
their materials and information to the
public in a timely manner, OADC is
requesting a three year extension of this
information collection. The estimated
annualized burden hours is 2,470. There
is no cost to the respondents other than
their time.
what attitudinal and structural barriers
may inhibit primary care provider
adoption of the recommendations in the
Guideline.
Over 10,000 respondents were
queried and over 4,500 burden hours
used during this time period. Because
the availability of this ICR has been so
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total
burden
(in hours)
Type of respondents
Form name
Public Health Professionals, Health
Care Providers, State and Local
Public Health Officials, Emergency
Responders, General Public.
Moderator’s
Guides,
Eligibility
Screeners,
Interview
Guides,
Opinion Surveys, Consent Forms.
18,525
1
8/60
2,470
Total ...........................................
...........................................................
........................
........................
........................
2,470
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–14796 Filed 7–10–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of closed meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC).
DATES: The meeting will be held on
August 1, 2018, 1:00 p.m. to 3:00 p.m.,
EDT (CLOSED).
ADDRESSES: Teleconference.
FOR FURTHER INFORMATION CONTACT:
Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for
Science, NCIPC, CDC, 4770 Buford
Highway NE, Mailstop F–63, Atlanta,
GA 30341, Telephone (770) 488–1430,
Email address: NCIPCBSC@cdc.gov.
SUPPLEMENTARY INFORMATION: The
meeting will be closed to the public in
accordance with provisions set forth in
Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:26 Jul 10, 2018
Jkt 244001
Director, Management Analysis and
Services Office, CDC, pursuant to Public
Law 92–463.
Purpose: The Board of Scientific
Counselors makes recommendations
regarding policies, strategies, objectives,
and priorities; and reviews progress
toward injury and violence prevention.
The Board also provides advice on the
appropriate balance of intramural and
extramural research, and guidance on
the needs, structure, progress and
performance of intramural programs.
The Board also provides guidance on
extramural scientific program matters,
including the: (1) Review of extramural
research concepts for funding
opportunity announcements; (2)
conduct of secondary peer review of
extramural research grants, cooperative
agreements, and contracts applications
received in response to the funding
opportunity announcements as they
relate to the Center’s programmatic
balance and mission; (3) submission of
secondary review recommendations to
the Center Director relating to
applications to be considered for
funding support; (4) review of research
portfolios, and (5) review of program
proposals.
Matters To Be Considered: The agenda
will include discussions on secondary
peer review of extramural research grant
and cooperative agreement applications
received in response to two (2) Notice
of Funding Opportunities (NOFOs):
RFA–CE–18–001, Research Grants for
Preventing Violence and Violence
Related Injury (RO1); SBIR PA–17–302,
PHS 2017–2 Omnibus Solicitation of the
NIH, CDC and FDA for Small Business
Innovation Research Grants. Agenda
items are subject to change as priorities
dictate.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–14754 Filed 7–10–18; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–18–0792]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Environmental
Health Specialists Network (EHS–NET)
Program to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on April 17,
2018 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
E:\FR\FM\11JYN1.SGM
11JYN1
Agencies
[Federal Register Volume 83, Number 133 (Wednesday, July 11, 2018)]
[Notices]
[Pages 32124-32126]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-14796]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-18-0572]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Health Message Testing System (HMTS) to the
Office of Management and Budget (OMB) for review and approval. CDC
previously
[[Page 32125]]
published a ``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on May 10, 2018 to obtain comments from the
public and affected agencies. CDC received one non-substantive comment.
This notice serves to allow an additional 30 days for public and
affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Health Message Testing System (HMTS) 0920-0572, Reinstatement
without change, Office of the Associate Director for Communication
(OADC), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Before CDC disseminates a health message to the public, the message
always undergoes scientific review. However, even though the message is
based on sound scientific content, there is no guarantee that the
public will understand a health message or that the message will move
people to take recommended action. Communication theorists and
researchers agree that for health messages to be as clear and
influential as possible, target audience members or representatives
must be involved in developing the messages and provisional versions of
the messages must be tested with members of the target audience.
However, increasingly there are circumstances when CDC must move
swiftly to protect life, prevent disease, or calm public anxiety.
Health message testing is even more important in these instances,
because of the critical nature of the information need.
In the interest of timely health message dissemination, many
programs forgo the important step of testing messages on dimensions
such as clarity, salience, appeal, and persuasiveness (i.e., the
ability to influence behavioral intention). Skipping this step avoids
the delay involved in the standard OMB review process, but at a high
potential cost. Untested messages can waste communication resources and
opportunities because the messages can be perceived as unclear or
irrelevant. Untested messages can also have unintended consequences,
such as jeopardizing the credibility of Federal health officials.
The Health Message Testing System (HMTS), a generic information
collection, enables programs across CDC to collect the information they
require in a timely manner to:
Ensure quality and prevent waste in the dissemination of
health information by CDC to the public.
Refine message concepts and to test draft materials for
clarity, salience, appeal, and persuasiveness to target audiences.
Guide the action of health communication officials who are
responding to health emergencies, Congressionally-mandated campaigns
with short timeframes, media-generated public concern, time-limited
communication opportunities, trends, and the need to refresh materials
or dissemination strategies in an ongoing campaign.
Each testing instrument will be based on specific health issues or
topics. Although it is not possible to develop one instrument for use
in all instances, the same kinds of questions are asked in most message
testing. This package includes generic questions and formats that can
used to develop health message testing data collection instruments.
These include a list of screening questions, comprised of demographic
and introductory questions, along with other questions that can be used
to create a mix of relevant questions for each proposed message testing
data collection method. However, programs may request to use additional
questions if needed.
Message testing questions will focus on issues such as
comprehension, impressions, personal relevance, content and wording,
efficacy of response, channels, and spokesperson/sponsor. Such
information will enable message developers to enhance the effectiveness
of messages for intended audiences.
Data collection methods proposed for HMTS include intercept
interviews, telephone interviews, focus groups, online surveys, and
cognitive interviews. In almost all instances, data will be collected
by outside organizations under contract with CDC.
For many years CDC programs have used HMTS to test and refine
message concepts and test draft materials for clarity, salience,
appeal, and persuasiveness to target audiences. Having this generic
clearance available has enabled them to test their information and get
critical health information out to the public quickly. Over the last
three years, more than 30 messages have been tested using this
clearance. For example: Domestic Readiness Initiative on Zika Virus
Disease-Year 2 Core Campaign Materials. As part of the mission of CDC's
Domestic Readiness Initiative on the Zika Virus Disease, CDC collected
information to inform an outcome evaluation to determine the extent to
which the campaign affected awareness, attitudes, and intention to
follow recommended behaviors at different points during the campaign.
The goal of the evaluation was to better understand awareness of
campaign activities, how people perceive Zika as a health risk, and
assess their uptake of recommended health behaviors, such as applying
insect repellent, using condoms, and wearing long-sleeved clothing.
The Division of Unintentional Injury Prevention obtained OMB
approval through HMTS for Assessing Perception and Use of CDC Guideline
for Prescribing Opioids for Chronic Pain. The purpose of this
collection is to assess primary care physician's perceptions and use of
communication materials and products associated with the CDC Guideline
for Prescribing Opioids for Chronic Pain. Information collected can
assist in the most effective use of CDC communication resources and
opportunities by assessing clarity, salience, appeal, persuasiveness
and effectiveness of materials promoting the dissemination and
implementation of the Guideline. Specifically, CDC seeks
[[Page 32126]]
to understand how primary care physicians perceive, need, and implement
the Guideline to make prescribing decisions; how they need, obtain, and
use supplementary and promotional Guideline materials developed by CDC
for professional development or patient education; and what attitudinal
and structural barriers may inhibit primary care provider adoption of
the recommendations in the Guideline.
Over 10,000 respondents were queried and over 4,500 burden hours
used during this time period. Because the availability of this ICR has
been so critical to programs in disseminating their materials and
information to the public in a timely manner, OADC is requesting a
three year extension of this information collection. The estimated
annualized burden hours is 2,470. There is no cost to the respondents
other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Public Health Professionals, Moderator's 18,525 1 8/60 2,470
Health Care Providers, State Guides,
and Local Public Health Eligibility
Officials, Emergency Screeners,
Responders, General Public. Interview
Guides, Opinion
Surveys,
Consent Forms.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 2,470
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Acting Chief, Information Collection Review Office, Office of
Scientific Integrity, Office of the Associate Director for Science,
Office of the Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-14796 Filed 7-10-18; 8:45 am]
BILLING CODE 4163-18-P